Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOAT1 | P35610 | 5/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16683901 | 0.89 | SOAT1 (0.65) | SOAT1 | |
| SCHEMBL12620884 | 0.89 | SOAT1 (0.65) | SOAT1 | |
| SCHEMBL12620900 | 0.87 | SOAT1 (0.60) | SOAT1 | |
| SCHEMBL12620912 | 0.87 | SOAT1 (0.60) | SOAT1 | |
| SCHEMBL12620825 | 0.85 | SOAT1 (0.60) | SOAT1 | |
| SCHEMBL12620823 | 0.84 | SOAT1 (0.53) | SOAT1 | |
| SCHEMBL7654433 | 0.83 | SOAT1 (0.60) | SOAT1 | |
| SCHEMBL12653722 | 0.82 | SOAT1 (0.55) | SOAT1 | |
| SCHEMBL19235665 | 0.81 | SOAT1 (1.00) | SOAT1 | |
| SCHEMBL12620914 | 0.80 | SOAT1 (0.48) | SOAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7935726-B1 | Tricyclic pyrones | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2011-05-03 | — | — | US | disclosed |
| US-7935726-B1 | Tricyclic pyrones | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2011-05-03 | — | — | US | disclosed |
| US-7935726-B1 | Tricyclic pyrones | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2011-05-03 | — | — | US | disclosed |
| US-6916824-B1 | Methods of treating cataracts and diabetic retinopathy with tricyclic pyrones | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2005-07-12 | — | — | US | disclosed |
| US-6384045-B1 | TREATMENT OF ALZHEIMER'S DISEASE AND ANTICANCER AGENTS | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION | 2002-05-07 | — | — | US | disclosed |